Humatica’s multi-part series on the Critical Success Factors of Buy & Builds. Read now

closeicon

Humatica’s multi-part series on the Critical Success Factors of Buy & Builds. Read now

closeicon

Humatica advises Baird Capital on their investment in Azzur Group

ndetails

Humatica, the leading private equity specialist advisor for portfolio company organisational effectiveness, has advised  Baird Capital’s private equity team on its investment in Azzur Group. Azzur is a provider of professional services to FDA regulated industries, helping life science customers navigate the regulatory complexities of product development, manufacturing, and commercialization.

Azzur Group operates three lines of business: Consulting, LabServices, and the recently launched Cleanrooms on Demand (COD). All of Azzur Group’s business lines have experienced strong growth for the past years while sporting robust margins. Baird’s investment will support the growth targets of Azzur Group’s various service lines, and especially on the COD’s rapid build-out.

Humatica was engaged by Baird Capital to provide Organisational Due Diligence advice for this transaction.

Marcel Bättig, Humatica Partner, commented:

“The transaction demonstrates Humatica’s capability to perform an organizational due diligence fully virtually, while building strong rapport with the management team of the company. It also shows that partnering with both the fund and the company maximizes deal value and mutual trust. We wish Azzur Group’s management team continued success and are proud to have assisted Baird Capital on this transaction.”

Brett Tucker, Baird Capital Partner, added:

“Baird Capital has a history of investing in pharma services businesses, and we look forward to bringing our resources, relationships, and experiences to support Azzur’s future growth. We are excited to partner with Azzur and its strong leadership team to help them build on their past successes.”

The Humatica team was led by Marcel Bättig, Partner.

To download the news release in PDF format, click here.

Related News

Humatica advises Freshstream on their investment in the UK’s leading security technology group, including SmartWater® and Perimeter Intruder Detection (PID) Systems
30 Mar, 2021 By Humatica

Humatica advises Freshstream on their investment in the UK’s leading security technology group, including SmartWater® and Perimeter Intruder Detection (PID) Systems

Humatica, the leading private equity specialist advisor for portfolio organisational effectiveness, has advised private equity firm Freshstream on its investment in a group containing the UK’s leading security technologists, including SmartWater® and Perimeter…

Read more arrowicon
Humatica advises Intermediate Capital Group (ICG) on their investment in Lucid Group
17 Mar, 2021 By Humatica

Humatica advises Intermediate Capital Group (ICG) on their investment in Lucid Group

Humatica, the leading private equity specialist advisor for portfolio organisational effectiveness, has advised private equity firm Intermediate Capital Group (ICG) on its investment in Lucid Group. Founded in 2007, Lucid Group is a…

Read more arrowicon
Humatica supports HVD Partners with sale of Solifos AG
10 Dec, 2020 By Humatica

Humatica supports HVD Partners with sale of Solifos AG

Humatica, the leading private equity specialist advisor for portfolio organizational effectiveness, is proud to have supported HVD Partners and the Solifos AG management with the…

Read more arrowicon

Subscribe to our Monthly Newsletter and other News Updates

Receive our news and valuable perspectives on organizational effectiveness each month.

I agree to Humatica’s Data Protection Policy and that Humatica may use my data to contact me via email.